VINCENT RICHARD G

CIK 00012693414 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001269341

Recent Transactions

50 trades

Award
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2026-05-29+18,353→ 18,353 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2025-03-20+31,000→ 31,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2024-09-17+2,000→ 2,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2024-02-14+14,200→ 14,200 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2024-01-03$0.50/sh−8,868→ 140,922 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−109,579→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+280,000→ 280,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+210,000→ 210,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−210,000→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+75,000→ 75,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+35,120→ 35,120 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+109,597→ 109,597 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+28,750→ 28,750 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−35,120→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−28,750→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−75,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−280,000→ 0 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-07-03$0.36/sh−7,069→ 149,790 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-13$0.30/sh+30,000→ 156,859 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-02-21+210,000→ 210,000 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-01-03$1.02/sh−4,428→ 126,859 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-07-28+28,750→ 28,750 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-07-28+43,125→ 131,287 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-03-28$1.40/sh+2,500→ 88,162 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-03-25$1.48/sh+5→ 83,526 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-03-25$1.45/sh+356→ 83,521 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-03-25$1.49/sh+2,136→ 85,662 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-03-24$1.45/sh+3→ 83,165 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-01-28$1.65/sh+2,500→ 83,162 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-01-27$1.80/sh+5,000→ 75,662 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2022-01-27$1.70/sh+5,000→ 80,662 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-01-20+109,579→ 109,579 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-01-03+29,867→ 70,662 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2021-02-11+280,000→ 280,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2020-03-17−35,120→ 35,120 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2020-03-17+35,120→ 35,120 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2019-09-12+75,000→ 75,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2019-09-12−75,000→ 75,000 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2019-06-07+42,628→ 40,794 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2019-06-07+4,526→ 4,526 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2019-06-07+73,385→ 73,385 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2019-06-07+1,834→ 1,834 total
Award
Oncternal Therapeutics, Inc.
Warrants
2019-06-07+281→ 281 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2014-10-07+50,000→ 270,000 total
Award
Sorrento Therapeutics, Inc.
Stock Options
2013-10-29+100,000→ 220,000 total
Disposition to Issuer
Sorrento Therapeutics, Inc.
Non-qualified stock option
2012-09-30−725,000→ 2,275,000 total
Disposition to Issuer
Sorrento Therapeutics, Inc.
Non-qualified stock option
2012-09-30−725,000→ 2,275,000 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock options
2012-09-22+3,000,000→ 3,000,000 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock options
2012-02-06+125,000→ 125,000 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock options
2011-03-07+500,000→ 600,000 total

Companies

Recent Filings

Address

C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BUILDING 6

DALLAS, TX, 75247

View on SEC.gov